From January 1, 2024 to March 31, 2024, the company has repurchased 1,267,900 shares, representing 0.09% for CNY 34.98 million. With this, the company has completed the repurchase of 1,488,200 shares, representing 0.11% for CNY 39.23 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.8 CNY | -7.10% |
|
-8.64% | -22.01% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.01% | 4.6B | |
+16.57% | 8.36B | |
+3.08% | 7.69B | |
-9.60% | 3.58B | |
-19.14% | 3.22B | |
-6.31% | 1.28B | |
-26.93% | 1.11B | |
-7.66% | 887M | |
-16.16% | 856M | |
-5.26% | 814M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.